XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Stock Purchase Agreement
At-The-Market
Common Stock
Common Stock
Stock Purchase Agreement
Common Stock
At-The-Market
Additional Paid-In Capital
Additional Paid-In Capital
Stock Purchase Agreement
Additional Paid-In Capital
At-The-Market
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023       60,467,188              
Beginning balance at Dec. 31, 2023 $ 246,114     $ 6     $ 774,618     $ (127) $ (528,383)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock, net (in shares)         5,567,928 2,500,601          
Issuance of common stock, net   $ 20,000 $ 14,089   $ 1     $ 19,999 $ 14,089    
Issuance of common stock upon exercise of stock options (in shares)       80,936              
Issuance of common stock upon exercise of stock options 519           519        
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (in shares)       121,516              
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (109)           (109)        
Issuances of common stock under 2020 ESPP (in shares)       34,902              
Issuance of common stock under 2020 ESPP 84           84        
Stock-based compensation 6,215           6,215        
Change in unrealized loss, net on marketable securities (253)                 (253)  
Net loss (28,361)                   (28,361)
Other (in shares)       5,520              
Other (16)           (16)        
Ending balance (in shares) at Mar. 31, 2024       68,778,591              
Ending balance at Mar. 31, 2024 258,282     $ 7     815,399     (380) (556,744)
Beginning balance (in shares) at Dec. 31, 2023       60,467,188              
Beginning balance at Dec. 31, 2023 246,114     $ 6     774,618     (127) (528,383)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (70,743)                    
Ending balance (in shares) at Sep. 30, 2024       70,562,901              
Ending balance at Sep. 30, 2024 242,656     $ 7     841,320     455 (599,126)
Beginning balance (in shares) at Mar. 31, 2024       68,778,591              
Beginning balance at Mar. 31, 2024 258,282     $ 7     815,399     (380) (556,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       32,607              
Issuance of common stock upon exercise of stock options 135           135        
Stock-based compensation 6,381           6,381        
Change in unrealized loss, net on marketable securities (60)                 (60)  
Net loss (17,716)                   (17,716)
Other (in shares)       4,444              
Other 36           36        
Ending balance (in shares) at Jun. 30, 2024       68,815,642              
Ending balance at Jun. 30, 2024 247,058     $ 7     821,951     (440) (574,460)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock, net (in shares)           1,631,521          
Issuance of common stock, net     $ 10,280           10,280    
Issuance of common stock upon exercise of stock options (in shares)       1,714              
Issuance of common stock upon exercise of stock options 13           13        
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (in shares)       31,363              
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (85)           (85)        
Issuances of common stock under 2020 ESPP (in shares)       75,993              
Issuance of common stock under 2020 ESPP 298           298        
Stock-based compensation 8,831           8,831        
Change in unrealized loss, net on marketable securities 895                 895  
Net loss (24,666)                   (24,666)
Other (in shares)       6,668              
Other 32           32        
Ending balance (in shares) at Sep. 30, 2024       70,562,901              
Ending balance at Sep. 30, 2024 242,656     $ 7     841,320     455 (599,126)
Beginning balance (in shares) at Dec. 31, 2024       70,625,899              
Beginning balance at Dec. 31, 2024 215,986     $ 7     849,625     53 (633,699)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (in shares)       321,342              
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (155)           (155)        
Issuances of common stock under 2020 ESPP (in shares)       35,589              
Issuance of common stock under 2020 ESPP 109           109        
Stock-based compensation 5,507           5,507        
Change in unrealized loss, net on marketable securities (10)                 (10)  
Net loss (26,322)                   (26,322)
Other (in shares)       6,831              
Other 25           25        
Ending balance (in shares) at Mar. 31, 2025       70,989,661              
Ending balance at Mar. 31, 2025 195,140     $ 7     855,111     43 (660,021)
Beginning balance (in shares) at Dec. 31, 2024       70,625,899              
Beginning balance at Dec. 31, 2024 215,986     $ 7     849,625     53 (633,699)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock, net (in shares)     2,950,225                
Issuance of common stock, net     $ 7,500                
Net loss (84,508)                    
Ending balance (in shares) at Sep. 30, 2025       74,174,515              
Ending balance at Sep. 30, 2025 154,408     $ 7     872,521     87 (718,207)
Beginning balance (in shares) at Mar. 31, 2025       70,989,661              
Beginning balance at Mar. 31, 2025 195,140     $ 7     855,111     43 (660,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation 4,992           4,992        
Change in unrealized loss, net on marketable securities (73)                 (73)  
Net loss (26,020)                   (26,020)
Other (in shares)       17,422              
Other 25           25        
Ending balance (in shares) at Jun. 30, 2025       71,007,083              
Ending balance at Jun. 30, 2025 174,064     $ 7     860,128     (30) (686,041)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock, net (in shares)     2,950,225     2,950,225          
Issuance of common stock, net     $ 7,526           $ 7,526    
Issuance of common stock upon exercise of stock options (in shares)       50,000              
Issuance of common stock upon exercise of stock options 107           107        
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (in shares)       14,868              
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (24)           (24)        
Issuances of common stock under 2020 ESPP (in shares)       135,114              
Issuance of common stock under 2020 ESPP 164           164        
Stock-based compensation 4,593           4,593        
Change in unrealized loss, net on marketable securities 117                 117  
Net loss (32,166)                   (32,166)
Other (in shares)       17,225              
Other 27           27        
Ending balance (in shares) at Sep. 30, 2025       74,174,515              
Ending balance at Sep. 30, 2025 $ 154,408     $ 7     $ 872,521     $ 87 $ (718,207)